+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

Individual Research Grants 2026 (Bacterial Infections)

European Society of Clinical Microbiology and Infectious Diseases

ESCMID Research Grants help nurture the next generation of researchers in CM and ID, by providing an important start in their research funding journey. These grants offer a unique opportunity to explore bacterial infections & diseases or fungal/viral/parasitic infections & diseases in alternating years.

Funding and payment

ESCMID’s research grants offer up to 20K EUR per project. The grant can be used for the entirety or specific aspects of your project. Upon the signing of the grant agreement, 50% of the allocated funds are issued to the grantee’s institution, with the remaining 50% released upon the submission and approval of the final reports (refer to reporting below for more details). ESCMID also reserves up to 50K EUR each for two exceptional projects. Recognised by esteemed reviewers for their outstanding potential, selected projects have the possibility to receive this additional funding to drive their topics further.

ESCMID Förderverein Grants for Research in AMR and Emerging Infections

As part of the ESCMID strategy, the ESCMID Förderverein grant enhances funding for research projects focusing on Antimicrobial Resistance (AMR) or Emerging Infectious Diseases (EID). This support benefits both individual researchers and SGs. As part of this initiative, four additional grants are awarded annually. To qualify, projects must address the challenges posed by AMR and/or EID, aligning with the specified theme for the year. Applications are integrated into the standard grant calls, with clear indications provided in the application form.

AI Based Application Success Predictor

1. ESCMID Young Investigator Award

A springboard for emerging scientists:

Notable Recipient: Norbert Pardi, the Hungarian biochemist pivotal in mRNA vaccine development (notably for COVID-19), received the Young Investigator Award in 2020. This award clearly underscores its role in recognizing future innovators.

Another early trailblazer: Mihai Netea, renowned for contributions in innate immunity, received the ESCMID Young Investigator Award back in 2005—a testament to the long-standing legacy of this award in fostering scientific excellence.

2. ESCMID Excellence Award

Celebrates established leaders with significant contributions:

Ilaria Capua, an authority in virology and science communication, received ESCMID’s Excellence Award in 2014, highlighting her impactful work in outbreak reporting and advocacy.

Similarly, Dimitrios Kontoyiannis, a respected expert in fungal pathogenesis and clinical microbiology, was honored with the ESCMID Award of Excellence in 2018—further illustrating the award’s prestige in recognizing high-impact contributors.

Why These Awards Serve as "Success Predictors"

Early Recognition: The Young Investigator Award helps spotlight emerging talent at critical career junctures, often preceding significant scientific breakthroughs or leadership roles.

Sustained Influence: The Excellence Award typically acknowledges mid- to late-career professionals whose work has shaped clinical microbiology or infectious diseases—making it both a recognition of past achievements and a predictor of continued leadership.

Summary Table

Award Name	Year Awarded	Recipient	Notable Later Impact
Young Investigator Award	2005	Mihai Netea	Emerged as a leading figure in innate immunity research.
	2020	Norbert Pardi	Became a pioneer in mRNA vaccine technology.
Excellence Award	2014	Ilaria Capua	Influential in virology and science advocacy.
	2018	Dimitrios Kontoyiannis	Established expert in fungal infections and clinical microbiology.

Additional Insights

ESCMID also runs various research grants—such as Individual Research Grants, Study Group Research Grants, and the Study Group Collaboration Grant—which foster collaborative, peer-recognized projects across Europe. While detailed past recipient lists aren't publicly accessible, their role in facilitating high-quality, cross-national research is noteworthy.

Specialties

Infectious Diseases

Microbiology

Eligibility Requirements

Qualify for a research grant opportunity by meeting the following criteria:

Serve as the principal investigator for the proposed research project
Hold a valid ESCMID Young Scientist Membership (YSM) or ESCMID low- or middle-income country (LMIC) membership*
Have a medical degree (MD, MBBS, PharmD, or equivalent), a PhD, or be actively enrolled in a PhD programme

Applicants who have received any ESCMID Research Grant (Individual, Study Group or SG Collaboration) may only apply for a subsequent grant in the year after official completion of the first project. Additionally, you cannot be awarded more than one ESCMID Research Grant (Individual, Study Group or SG Collaboration) in a single year or be listed as principal investigator in more than one concurrent project. Please be aware that members of the ESCMID Executive Committee (EC) are not eligible to apply for research grants or provide support letters for applications.

Sponsor Details

Sponsor Institute/Organizations: European Society of Clinical Microbiology and Infectious Diseases

Sponsor Type: Corporate/Non-Profit

Address: Aeschenvorstadt 55 4051 Basel SWITZERLAND

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity